These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 30488666)

  • 1. FAM3B (PANDER) functions as a co-activator of FOXO1 to promote gluconeogenesis in hepatocytes.
    Chi Y; Meng Y; Wang J; Yang W; Wu Z; Li M; Wang D; Gao F; Geng B; Tie L; Zhang W; Yang J
    J Cell Mol Med; 2019 Mar; 23(3):1746-1758. PubMed ID: 30488666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pancreatic-derived factor promotes lipogenesis in the mouse liver: role of the Forkhead box 1 signaling pathway.
    Li J; Chi Y; Wang C; Wu J; Yang H; Zhang D; Zhu Y; Wang N; Yang J; Guan Y
    Hepatology; 2011 Jun; 53(6):1906-16. PubMed ID: 21412813
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic Activation of the FAM3C-HSF1-CaM Pathway Attenuates Hyperglycemia of Obese Diabetic Mice.
    Chen Z; Ding L; Yang W; Wang J; Chen L; Chang Y; Geng B; Cui Q; Guan Y; Yang J
    Diabetes; 2017 May; 66(5):1185-1197. PubMed ID: 28246289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prostaglandin F
    Wang Y; Yan S; Xiao B; Zuo S; Zhang Q; Chen G; Yu Y; Chen D; Liu Q; Liu Y; Shen Y; Yu Y
    Diabetes; 2018 Sep; 67(9):1748-1760. PubMed ID: 29773555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
    Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
    Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GCN5L1 modulates cross-talk between mitochondria and cell signaling to regulate FoxO1 stability and gluconeogenesis.
    Wang L; Scott I; Zhu L; Wu K; Han K; Chen Y; Gucek M; Sack MN
    Nat Commun; 2017 Sep; 8(1):523. PubMed ID: 28900165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PANDER transgenic mice display fasting hyperglycemia and hepatic insulin resistance.
    Robert-Cooperman CE; Dougan GC; Moak SL; Athanason MG; Kuehl MN; Bell-Temin H; Stevens SM; Burkhardt BR
    J Endocrinol; 2014 Mar; 220(3):219-31. PubMed ID: 24468680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long non-coding RNA H19 inhibition promotes hyperglycemia in mice by upregulating hepatic FoxO1 levels and promoting gluconeogenesis.
    Goyal N; Tiwary S; Kesharwani D; Datta M
    J Mol Med (Berl); 2019 Jan; 97(1):115-126. PubMed ID: 30465059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zbtb7c is a critical gluconeogenic transcription factor that induces glucose-6-phosphatase and phosphoenylpyruvate carboxykinase 1 genes expression during mice fasting.
    Choi WI; Yoon JH; Song JY; Jeon BN; Park JM; Koh DI; Ahn YH; Kim KS; Lee IK; Hur MW
    Biochim Biophys Acta Gene Regul Mech; 2019 Jun; 1862(6):643-656. PubMed ID: 30959128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogen Improves Insulin Sensitivity and Suppresses Gluconeogenesis via the Transcription Factor Foxo1.
    Yan H; Yang W; Zhou F; Li X; Pan Q; Shen Z; Han G; Newell-Fugate A; Tian Y; Majeti R; Liu W; Xu Y; Wu C; Allred K; Allred C; Sun Y; Guo S
    Diabetes; 2019 Feb; 68(2):291-304. PubMed ID: 30487265
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual Regulation of Gluconeogenesis by Insulin and Glucose in the Proximal Tubules of the Kidney.
    Sasaki M; Sasako T; Kubota N; Sakurai Y; Takamoto I; Kubota T; Inagi R; Seki G; Goto M; Ueki K; Nangaku M; Jomori T; Kadowaki T
    Diabetes; 2017 Sep; 66(9):2339-2350. PubMed ID: 28630133
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
    Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
    Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver-specific overexpression of pancreatic-derived factor (PANDER) induces fasting hyperglycemia in mice.
    Wilson CG; Schupp M; Burkhardt BR; Wu J; Young RA; Wolf BA
    Endocrinology; 2010 Nov; 151(11):5174-84. PubMed ID: 20844005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.
    Puigserver P; Rhee J; Donovan J; Walkey CJ; Yoon JC; Oriente F; Kitamura Y; Altomonte J; Dong H; Accili D; Spiegelman BM
    Nature; 2003 May; 423(6939):550-5. PubMed ID: 12754525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA Gomafu upregulates Foxo1 expression to promote hepatic insulin resistance by sponging miR-139-5p.
    Yan C; Li J; Feng S; Li Y; Tan L
    Cell Death Dis; 2018 Feb; 9(3):289. PubMed ID: 29459686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. TOX3 deficiency mitigates hyperglycemia by suppressing hepatic gluconeogenesis through FoxO1.
    Liu C; Zheng Y; Hu S; Liang X; Li Y; Yu Z; Liu Y; Bian Y; Man Y; Zhao S; Liu X; Liu H; Huang T; Ma J; Chen ZJ; Zhao H; Zhang Y
    Metabolism; 2024 Mar; 152():155766. PubMed ID: 38145825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor.
    Yu L; Wang Z; Huang M; Li Y; Zeng K; Lei J; Hu H; Chen B; Lu J; Xie W; Zeng S
    Biochim Biophys Acta; 2016 Sep; 1859(9):1100-1111. PubMed ID: 26455953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDB1-Mediated CRY1 Degradation Promotes FOXO1-Driven Gluconeogenesis in Liver.
    Tong X; Zhang D; Charney N; Jin E; VanDommelen K; Stamper K; Gupta N; Saldate J; Yin L
    Diabetes; 2017 Oct; 66(10):2571-2582. PubMed ID: 28790135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipocalin-2: a role in hepatic gluconeogenesis via AMP-activated protein kinase (AMPK).
    Sun WX; Lou K; Chen LJ; Liu SD; Pang SG
    J Endocrinol Invest; 2021 Aug; 44(8):1753-1765. PubMed ID: 33423221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.